Volker Gatterdam
Goethe University Frankfurt
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Volker Gatterdam.
Nature Nanotechnology | 2012
Ruoshan Wei; Volker Gatterdam; Ralph Wieneke; Robert Tampé; Ulrich Rant
Solid-state nanopores are capable of the label-free analysis of single molecules. It is possible to add biochemical selectivity by anchoring a molecular receptor inside the nanopore, but it is difficult to maintain single-molecule sensitivity in these modified nanopores. Here, we show that metallized silicon nitride nanopores chemically modified with nitrilotriacetic acid receptors can be used for the stochastic sensing of proteins. The reversible binding and unbinding of the proteins to the receptors is observed in real time, and the interaction parameters are statistically analysed from single-molecule binding events. To demonstrate the versatile nature of this approach, we detect His-tagged proteins and discriminate between the subclasses of rodent IgG antibodies.
Journal of Biological Chemistry | 2012
Jessica Hartmann; Thuy-Van Tran; Janina Kaudeer; Karin Oberle; Julia Herrmann; Isabell Quagliano; Tobias Abel; André Cohnen; Volker Gatterdam; Andrea Jacobs; Bernd Wollscheid; Robert Tampé; Carsten Watzl; Andreas Diefenbach; Joachim Koch
Background: NKp30 is a major activating receptor of natural killer (NK) cells. Results: The stalk domain of NKp30 increases ligand binding affinity, which is modulated by glycosylation of the ectodomain of NKp30. Conclusion: The stalk domain and the glycosylation status of NKp30 are critical for NK cell killing. Significance: This is the first hint for a novel mode of receptor regulation. The natural cytotoxicity receptors are a unique set of activating proteins expressed mainly on the surface of natural killer (NK) cells. The human natural cytotoxicity receptor family comprises the three type I membrane proteins NKp30, NKp44, and NKp46. Especially NKp30 is critical for the cytotoxicity of NK cells against different targets including tumor, virus-infected, and immature dendritic cells. Although the crystal structure of NKp30 was recently solved (Li, Y., Wang, Q., and Mariuzza, R. A. (2011) J. Exp. Med. 208, 703–714; Joyce, M. G., Tran, P., Zhuravleva, M. A., Jaw, J., Colonna, M., and Sun, P. D. (2011) Proc. Natl. Acad. Sci. U.S.A. 108, 6223–6228), a key question, how NKp30 recognizes several non-related ligands, remains unclear. Therefore, we investigated the parameters that impact ligand recognition of NKp30. Based on various NKp30-hIgG1-Fc fusion proteins, which were optimized for minimal background binding to cellular Fcγ receptors, we identified the flexible stalk region of NKp30 as an important but so far neglected module for ligand recognition and related signaling of the corresponding full-length receptor proteins. Moreover, we found that the ectodomain of NKp30 is N-linked glycosylated at three different sites. Mutational analyses revealed differential binding affinities and signaling capacities of mono-, di-, or triglycosylated NKp30, suggesting that the degree of glycosylation could provide a switch to modulate the ligand binding properties of NKp30 and NK cell cytotoxicity.
Angewandte Chemie | 2014
Volker Gatterdam; Radhan Ramadass; Tatjana Stoess; Manuela A. H. Fichte; Josef Wachtveitl; Alexander Heckel; Robert Tampé
Spatial and temporal control over chemical and biological processes plays a key role in life and material sciences. Here we synthesized a two-photon-activatable glutathione (GSH) to trigger the interaction with glutathione S-transferase (GST) by light at superior spatiotemporal resolution. The compound shows fast and well-confined photoconversion into the bioactive GSH, which is free to interact with GST-tagged proteins. The GSH/GST interaction can be phototriggered, changing its affinity over several orders of magnitude into the nanomolar range. Multiplexed three-dimensional (3D) protein networks are simultaneously generated in situ through two-photon fs-pulsed laser-scanning excitation. The two-photon activation facilitates the three-dimensional assembly of protein structures in real time at hitherto unseen resolution in time and space, thus opening up new applications far beyond the presented examples.
Angewandte Chemie | 2012
Volker Gatterdam; Tatjana Stoess; Clara Menge; Alexander Heckel; Robert Tampé
Light, GSH, action! Glutathione (GSH) fulfills a universal role as redox factor, scavenger of reactive oxygen species, and as an essential substrate in the conjugation, detoxification, and reduction reactions catalyzed by glutathione S-transferase (GST). A photoactivatable glutathione allows the GSH-GST network to be triggered by light. GST fusion proteins can be assembled in situ at variable density and structures by laser-scanning activation.
Biochemical Pharmacology | 2017
Sabrina Khageh Hosseini; Stefanie Kolterer; Marlene Steiner; Viktoria von Manstein; Katharina Gerlach; Jörg Trojan; Oliver Waidmann; Stefan Zeuzem; Jörg O. Schulze; Steffen Hahn; Dieter Steinhilber; Volker Gatterdam; Robert Tampé; Ricardo M. Biondi; Ewgenij Proschak; Martin Zörnig
Graphical abstract Figure. No Caption available. ABSTRACT The transcriptional regulator FUSE Binding Protein 1 (FUBP1) is overexpressed in more than 80% of all human hepatocellular carcinomas (HCCs) and other solid tumor entities including prostate and colorectal carcinoma. FUBP1 expression is required for HCC tumor cell expansion, and it functions as an important pro‐proliferative and anti‐apoptotic oncoprotein that binds to the single‐stranded DNA sequence FUSE to regulate the transcription of a variety of target genes. In this study, we screened an FDA‐approved drug library and discovered that the Topoisomerase I (TOP1) inhibitor camptothecin (CPT) and its derivative 7‐ethyl‐10‐hydroxycamptothecin (SN‐38), the active irinotecan metabolite that is used in the clinics in combination with other chemotherapeutics to treat carcinoma, inhibit FUBP1 activity. Both molecules prevent in vitro the binding of FUBP1 to its single‐stranded target DNA FUSE, and they induce deregulation of FUBP1 target genes in HCC cells. Our results suggest the interference with the FUBP1/FUSE interaction as a further molecular mechanism that, in addition to the inactivation of TOP1, may contribute to the therapeutic potential of CPT/SN‐38. Targeting of FUBP1 in HCC therapy with SN‐38/irinotecan could be a particularly interesting option because of the high FUBP1 levels in HCC cells and their dependency on FUBP1 expression.
Angewandte Chemie | 2018
Karl Gatterdam; Eike F. Joest; Volker Gatterdam; Robert Tampé
Small chemical/biological interaction pairs are at the forefront in tracing protein function and interaction at high signal-to-background ratios in cellular pathways. However, the optimal design of scaffold, linker, and chelator head still deserve systematic investigation to achieve the highest affinity and kinetic stability for in vitro and especially cellular applications. We report on a library of N-nitrilotriacetic acid (NTA)-based multivalent chelator heads (MCHs) built on linear, cyclic, and dendritic scaffolds and compare these with regard to their binding affinity and stability for the labeling of cellular His-tagged proteins. Furthermore, we describe a new approach for tracing cellular target proteins at picomolar probe concentrations in cells. Finally, we outline fundamental differences between the MCH scaffolds and define a cyclic trisNTA chelator that displays the highest affinity and kinetic stability of all reported reversible, low-molecular-weight interaction pairs.
Retrovirology | 2014
Philipp Arnold; Patricia Himmels; Svenja Weiß; Tim-Michael Decker; Jürgen Markl; Volker Gatterdam; Robert Tampé; Patrick Bartholomäus; Ursula Dietrich; Ralf Dürr
BackgroundHIV-1 is decorated with trimeric glycoprotein spikes that enable infection by engaging CD4 and a chemokine coreceptor, either CCR5 or CXCR4. The variable loop 3 (V3) of the HIV-1 envelope protein (Env) is the main determinant for coreceptor usage. The predominant CCR5 using (R5) HIV-1 Env has been intensively studied in function and structure, whereas the trimeric architecture of the less frequent, but more cytopathic CXCR4 using (X4) HIV-1 Env is largely unknown, as are the consequences of sequence changes in and near V3 on antigenicity and trimeric Env structure.ResultsSoluble trimeric gp140 Env constructs were used as immunogenic mimics of the native spikes to analyze their antigenic properties in the context of their overall 3D structure. We generated soluble, uncleaved, gp140 trimers from a prototypic T-cell line-adapted (TCLA) X4 HIV-1 strain (NL4-3) and a hybrid (NL4-3/ADA), in which the V3 spanning region was substituted with that from the primary R5 isolate ADA. Compared to an ADA (R5) gp140, the NL4-3 (X4) construct revealed an overall higher antibody accessibility, which was most pronounced for the CD4 binding site (CD4bs), but also observed for mAbs against CD4 induced (CD4i) epitopes and gp41 mAbs. V3 mAbs showed significant binding differences to the three constructs, which were refined by SPR analysis. Of interest, the NL4-3/ADA construct with the hybrid NL4-3/ADA CD4bs showed impaired CD4 and CD4bs mAb reactivity despite the presence of the essential elements of the CD4bs epitope. We obtained 3D reconstructions of the NL4-3 and the NL4-3/ADA gp140 trimers via electron microscopy and single particle analysis, which indicates that both constructs inherit a propeller-like architecture. The first 3D reconstruction of an Env construct from an X4 TCLA HIV-1 strain reveals an open conformation, in contrast to recently published more closed structures from R5 Env. Exchanging the X4 V3 spanning region for that of R5 ADA did not alter the open Env architecture as deduced from its very similar 3D reconstruction.Conclusions3D EM analysis showed an apparent open trimer configuration of X4 NL4-3 gp140 that is not modified by exchanging the V3 spanning region for R5 ADA.
Angewandte Chemie | 2012
Volker Gatterdam; Tatjana Stoess; Clara Menge; Alexander Heckel; Robert Tampé
Angewandte Chemie | 2014
Volker Gatterdam; Radhan Ramadass; Tatjana Stoess; Manuela A. H. Fichte; Josef Wachtveitl; Alexander Heckel; Robert Tampé
Nature Nanotechnology | 2017
Volker Gatterdam; Andreas Frutiger; Klaus-Peter Stengele; Dieter Heindl; Thomas Lübbers; Janos Vörös; Christof Fattinger